Misoprostol with isosorbide in therapeutic abortion

Comparing the effects of misoprostol with isosorbide in abortion

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250826067009N1

Enrollment

150

Registered

2025-09-07

Start date

2025-09-23

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abortion. Spontaneous abortion

Interventions

Intervention 1: Intervention group: The first group was treated with 200 micrograms of sublingual misoprostol tablets, 400 micrograms every 4 hours, up to a maximum of 5 doses. The drug was manufactur

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Aged between 18 and 45 years old Pregnancy less than 20 weeks

Exclusion criteria

Exclusion criteria: History of Cesarean more than 2 times Uncontrolled high blood pressure Cancers Uncontrolled diabetes

Design outcomes

Primary

Measure	Time frame
Successful abortion. Timepoint: 24 hours after drug administration. Method of measurement: Physical examination and blood test for Bhcg levels.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactVida Goodarzi

Esfahan University of Medical Sciences

Vidagodarzi993@gmail.com+98 31 3668 7898

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026